(Q38913488)

7 September 2017

PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells (English)

1 reference

7 September 2017

0 references

Mélissa Boisvert

1

1 reference

7 September 2017

Sandra Côté

2

1 reference

7 September 2017

Amandine Vargas

3

1 reference

7 September 2017

Stamatoula Pasvanis

4

1 reference

7 September 2017

Salim Bounou

5

1 reference

7 September 2017

Benoit Barbeau

6

1 reference

7 September 2017

Nancy Dumais

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

7 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

7 September 2017

380

1 reference

7 September 2017

1

1 reference

7 September 2017

1-11

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

7 September 2017

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective activation of PPARgamma in breast, colon, and lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Antiproliferative prostaglandins activate heat shock transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Development of an in vitro organ culture model to study transmissionof HIV-1 in the female genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Emerging roles of PPARs in inflammation and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The organization, promoter analysis, and expression of the human PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Peroxisome proliferator-activated receptor γ activators inhibit interleukin-12 production in murine dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Prostaglandin D2, a potential antineoplastic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Inducible cyclooxygenase may have anti-inflammatory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Prostaglandins as modulators of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Role of cyclopentenone prostaglandins in rat carrageenin pleurisy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Prostaglandin D2: a biochemical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The Role of Mucosal Immunity in Prevention of HIV Transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Inhibition of Sindbis virus replication by cyclopentenone prostaglandins: a cell-mediated event associated with heat-shock protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Epithelial M cells: gateways for mucosal infection and immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

DC-SIGN and DC-SIGNR: helping hands for HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

NF-kappa B and HIV: linking viral and immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immune deficiency virus-infected drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Sexual transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

PPAR gamma signaling exacerbates mammary gland tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Prostaglandin A compounds as antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

The relationship between prostaglandins and virus replication: Endogenous prostaglandin synthesis during infection and the effect of exogenous PGA on virus production in different cell lines and in persistently infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

NF-kappaB and virus infection: who controls whom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

15d-PGJ2: the anti-inflammatory prostaglandin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Structure, regulation and function of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Weight loss, the gut and the inflammatory response in aids patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

gp120-independent HIV infection of cells derived from the female reproductive tract, brain, and colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.07.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.07.023

1 reference

7 September 2017

1 reference